Literature DB >> 23817430

Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.

Robin Ireland1, Rong Wang, Joshua B Alinger, Pamela Small, Catharine M Bosio.   

Abstract

Induction of innate immunity is essential for host survival of infection. Evasion and inhibition of innate immunity constitute a strategy used by pathogens, such as the highly virulent bacterium Francisella tularensis, to ensure their replication and transmission. The mechanism and bacterial components responsible for this suppression of innate immunity by F. tularensis are not defined. In this article, we demonstrate that lipids enriched from virulent F. tularensis strain SchuS4, but not attenuated live vaccine strain, inhibit inflammatory responses in vitro and in vivo. Suppression of inflammatory responses is associated with IκBα-independent inhibition of NF-κBp65 activation and selective inhibition of activation of IFN regulatory factors. Interference with NF-κBp65 and IFN regulatory factors is also observed following infection with viable SchuS4. Together these data provide novel insight into how highly virulent bacteria selectively modulate the host to interfere with innate immune responses required for survival of infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817430      PMCID: PMC3729262          DOI: 10.4049/jimmunol.1300867

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Soviet viable Pasteurella tularensis vaccines. A review of selected articles.

Authors:  W D TIGERTT
Journal:  Bacteriol Rev       Date:  1962-09

2.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

3.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

4.  DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1.

Authors:  T Tamura; M Ishihara; M S Lamphier; N Tanaka; I Oishi; S Aizawa; T Matsuyama; T W Mak; S Taki; T Taniguchi
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

5.  A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity.

Authors:  R Lin; J Hiscott
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  Francisella tularensis induces aberrant activation of pulmonary dendritic cells.

Authors:  Catharine M Bosio; Steven W Dow
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter.

Authors:  X Ma; M Neurath; G Gri; G Trinchieri
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

8.  Minimal requirements for murine resistance to infection with Francisella tularensis LVS.

Authors:  K L Elkins; T R Rhinehart-Jones; S J Culkin; D Yee; R K Winegar
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 9.  Tularaemia: bioterrorism defence renews interest in Francisella tularensis.

Authors:  Petra C F Oyston; Anders Sjostedt; Richard W Titball
Journal:  Nat Rev Microbiol       Date:  2004-12       Impact factor: 60.633

10.  Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.

Authors:  J Wayne Conlan; Hua Shen; Rhonda Kuolee; Xigeng Zhao; Wangxue Chen
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

View more
  17 in total

1.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

2.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

3.  Microinjection of Francisella tularensis and Listeria monocytogenes reveals the importance of bacterial and host factors for successful replication.

Authors:  Lena Meyer; Jeanette E Bröms; Xijia Liu; Martin E Rottenberg; Anders Sjöstedt
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

4.  Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Authors:  Katharina Richard; Barbara J Mann; Aiping Qin; Eileen M Barry; Robert K Ernst; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

5.  Interferon Gamma Reprograms Host Mitochondrial Metabolism through Inhibition of Complex II To Control Intracellular Bacterial Replication.

Authors:  Forrest Jessop; Robert Buntyn; Benjamin Schwarz; Tara Wehrly; Dana Scott; Catharine M Bosio
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

6.  Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α.

Authors:  Deborah D Crane; Robin Ireland; Joshua B Alinger; Pamela Small; Catharine M Bosio
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

7.  Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.

Authors:  Shelly J Robertson; Kirk J Lubick; Brett A Freedman; Aaron B Carmody; Sonja M Best
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

8.  Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist.

Authors:  Kathie-Anne Walters; Rachael Olsufka; Rolf E Kuestner; Xiagang Wu; Kai Wang; Shawn J Skerrett; Adrian Ozinsky
Journal:  BMC Genomics       Date:  2015-10-28       Impact factor: 3.969

9.  Virulent Type A Francisella tularensis actively suppresses cytokine responses in human monocytes.

Authors:  Devyn D Gillette; Heather M Curry; Thomas Cremer; David Ravneberg; Kavin Fatehchand; Prexy A Shah; Mark D Wewers; Larry S Schlesinger; Jonathan P Butchar; Susheela Tridandapani; Mikhail A Gavrilin
Journal:  Front Cell Infect Microbiol       Date:  2014-04-10       Impact factor: 5.293

10.  Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.

Authors:  Amanda J Griffin; Deborah D Crane; Tara D Wehrly; Dana P Scott; Catharine M Bosio
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.